Optimus Announces Interim Clinical Results from Phase III Clinical Trials of Molnupiravir Conducted in India
Hyderabad (Telangana) , July 21: Optimus Pharma on Sunday submitted the interim result of Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild Covid-19 patients. With…